Use of Daratumumab in Patients With Previously Treated Multiple Myeloma

J Clin Oncol. 2023 May 10;41(14):2668. doi: 10.1200/JCO.22.02850. Epub 2023 Mar 20.

Author

Ashwin P Patel¹

Affiliation

¹ Ashwin P. Patel, MBBS, PhD, Emory University School of Medicine, Atlanta, GA.

PMID: 36940403
DOI: 10.1200/JCO.22.02850

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal / adverse effects
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Humans
Lenalidomide / therapeutic use
Multiple Myeloma* / drug therapy

Substances

daratumumab
Antibodies, Monoclonal
Lenalidomide